Lando Norris 'regrets' Lewis Hamilton comments after winning first F1 title

New F1 world champion Lando Norris regrets some of the things he's said about his rivals previously, especially Lewis Hamilton.

Who is Lando Norris? Everything you need to know about the new F1 world champion

Lando Norris has become Formula 1’s newest world champion with third place in the Abu Dhabi Grand Prix finale, taking the ...

Two of the UK's poshest villages are less than an hour from Bristol

According to the Times, you're likely to come across arty types such as Stella McCartney, Alice Temperley and Pearl Lowe in ...

'Zipcar closure means I may have to buy a car'

The mayor of London is being urged to help those affected by the potential closure of car sharing company Zipcar.
Pharmabiz

US FDA approves Bristol Myers Squibb’s Breyanzi for adults with relapsed or refractory marginal zone lymphoma

US FDA approves Bristol Myers Squibb’s Breyanzi for adults with relapsed or refractory marginal zone lymphoma: Princeton, New Jersey Saturday, December 6, 2025, 09:00 Hrs [IST] ...

Urgent warning over UK airport parking as cops target rogue firms after families left stranded & keys left in caravans

COPS have issued urgent warnings over off-site parking operators near Bristol Airport. The crackdown on rogue firms comes ...

Campaign to keep Bristol car parks free of charge

It includes 10 district car parks across the city which are currently free of charge, but the one at Westbury-on-Trym has ...

The easy trick to avoid airport drop-off charges

For holidaymakers who would rather avoid forking out on £7 drop-off charges at airports across the UK, there are a number of ...
Medical Dialogues

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

Princeton: Bristol Myers Squibb has received approval for Breyanzi (lisocabtagene maraleucel; liso-cel) from the U.S. Food ...
PharmiWeb

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)

In the MZL cohort of TRANSCEND FL, Breyanzi delivered deep and durable responses in 95.5% of patients while demonstrating a ...

FDA Approves Bristol Myers Squibb's Breyanzi As First CAR T Therapy For R/R Marginal Zone Lymphoma

Bristol Myers Squibb (BMY) announced that the U.S. Food and Drug Administration has approved Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen ...